A detailed history of Global Retirement Partners, LLC transactions in Catalent, Inc. stock. As of the latest transaction made, Global Retirement Partners, LLC holds 189 shares of CTLT stock, worth $11,525. This represents 0.0% of its overall portfolio holdings.

Number of Shares
189
Previous 357 47.06%
Holding current value
$11,525
Previous $20,000 45.0%
% of portfolio
0.0%
Previous 0.0%

Shares

17 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Oct 16, 2024

SELL
$56.16 - $60.96 $9,434 - $10,241
-168 Reduced 47.06%
189 $11,000
Q2 2024

Jul 23, 2024

SELL
$53.58 - $57.02 $8,572 - $9,123
-160 Reduced 30.95%
357 $20,000
Q1 2024

Apr 23, 2024

SELL
$42.56 - $59.82 $24,472 - $34,396
-575 Reduced 52.66%
517 $29,000
Q4 2023

Jan 18, 2024

SELL
$32.18 - $46.57 $15,864 - $22,959
-493 Reduced 31.1%
1,092 $49,000
Q3 2023

Oct 13, 2023

BUY
$44.2 - $50.2 $2,696 - $3,062
61 Added 4.0%
1,585 $72,000
Q2 2023

Jul 20, 2023

BUY
$31.86 - $67.26 $8,697 - $18,361
273 Added 21.82%
1,524 $66,000
Q1 2023

May 05, 2023

BUY
$45.44 - $74.26 $16,585 - $27,104
365 Added 41.2%
1,251 $82,000
Q4 2022

Feb 13, 2023

BUY
$41.39 - $81.0 $28,890 - $56,538
698 Added 371.28%
886 $39,000
Q3 2022

Nov 03, 2022

SELL
$72.36 - $113.1 $21,563 - $33,703
-298 Reduced 61.32%
188 $12,000
Q2 2022

Jul 15, 2022

BUY
$87.2 - $114.05 $261 - $342
3 Added 0.62%
486 $52,000
Q1 2022

Jul 14, 2022

BUY
$94.19 - $124.49 $45,493 - $60,128
483 New
483 $47,000
Q4 2021

Jan 21, 2022

SELL
$119.57 - $139.07 $26,424 - $30,734
-221 Closed
0 $0
Q3 2021

Oct 22, 2021

BUY
$109.17 - $142.35 $6,004 - $7,829
55 Added 33.13%
221 $29,000
Q2 2021

Jul 15, 2021

BUY
$100.34 - $115.69 $301 - $347
3 Added 1.84%
166 $18,000
Q1 2021

Apr 14, 2021

BUY
$101.51 - $125.27 $16,546 - $20,419
163 New
163 $17,000
Q4 2019

Jan 23, 2020

SELL
$47.06 - $56.64 $4,706 - $5,664
-100 Closed
0 $0
Q2 2019

Nov 19, 2019

BUY
$39.26 - $54.21 $3,926 - $5,421
100 New
100 $5,000

Others Institutions Holding CTLT

About Catalent, Inc.


  • Ticker CTLT
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 179,896,000
  • Market Cap $11B
  • Description
  • Catalent, Inc., together with its subsidiaries, develops and manufactures solutions for drugs, protein-based biologics, cell and gene therapies, and consumer health products worldwide. The Softgel and Oral Technologies segment provides formulation, development, and manufacturing services for soft capsules for use in a range of customer products,...
More about CTLT
Track This Portfolio

Track Global Retirement Partners, LLC Portfolio

Follow Global Retirement Partners, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Global Retirement Partners, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Global Retirement Partners, LLC with notifications on news.